Compare Raytheon Technologies Corp (RTX) vs Twist Bioscience Corp (TWST) Price & Performance

Raytheon Technologies CorpTrade

Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Raytheon Technologies Corp vs Twist Bioscience Corp — how do they compare? Raytheon Technologies Corp trades at $193.75 (market cap $261.85B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Raytheon Technologies Corp is far larger — about 48× Twist Bioscience Corp's market cap, and Raytheon Technologies Corp pays a 1.5% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

	RTX	TWST
Market Cap	$261.85B	$5.45B
Sector	Industrials	Health
52-Week High	$212.16	$102.88
52-Week Low	$149.17	$24.16
Enterprise Value	$293.97B	$5.37B
Dividend Yield	1.5%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Raytheon Technologies Corp

RTX trades at $193.51, down 0.44% today, with a bullish technical signal and strong analyst support. Recent contract wins, including a $515 million Navy radar deal (PRNewsWire, June 3, 2026), and earnings beats in Q4 2025 and Q1 2026 highlight operational momentum. Revenue growth accelerated to $88.6 billion in 2025, with net income margin improving to 8.03%. The stock faces resistance near $196-$199, with support at $192.

The outlook remains positive given defense spending tailwinds and production expansions, but elevated P/E of 36.48 poses valuation risk. Analysts project 10% upside to a $213 consensus target, with no sell ratings. Key risks include debt levels and geopolitical volatility affecting contracts.

Twist Bioscience Corp

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RTX

OpenAI and Anthropic boost lobbying to $3.17M in Q2 ahead of IPOs and midtermsCNBC · 8 hours agoNeutral Collins Aerospace and Etihad Engineering form JV to expand aircraft MRO services in Abu Dhabi.PRNewsWire · 9 hours agoBullish Tigerair Taiwan orders 15 Airbus A321neos with fuel-efficient Pratt & Whitney GTF engines.PRNewsWire · 9 hours agoBullish View details →

TWST

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 11 hours agoNeutral View details →

About Raytheon Technologies Corp

Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.